CHEBI:85662 - lixisenatide

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name lixisenatide
ChEBI ID CHEBI:85662
Definition A forty-four membered polypeptide consisting of L-His, Gly, L-Glu, Gly, L-Thr, L-Phe, L-Thr, L-Ser, L-Asp, L-Leu, L-Ser, L-Lys, L-Gln, L-Met, L-Glu, L-Glu, L-Glu, L-Ala, L-Val, L-Arg, L-Leu, L-Phe, L-Ile, L-Glu, L-Trp, L-Leu, L-Lys, L-Asn, Gly, Gly, LPro, L-Ser, L-Ser, Gly, L-Ala, L-Pro, L-Pro, L-Ser, L-Lys, L-Lys, L-Lys, L-Lys, L-Lys, and L-Lys-NH2 residues joined in sequence. Used as an adjunct to diet and exercise for the treatment of adults with type II diabetes.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C215H347N61O65S
Net Charge 0
Average Mass 4858.49000
Monoisotopic Mass 4855.54432
InChI InChI=1S/C215H347N61O65S/c1-16-115(10)173(210(337)256-141(68-74-170(299)300)194(321)261-148(94-122-98-232-126-50-24-23-49-124(122)126)199(326)258-143(89-111(2)3)196(323)247-134(58-32-40-83-223)189(316)262-149(96-160(226)285)180(307)235-100-161(286)233-104-165(290)274-85-42-60-156(274)207(334)267-154(108-280)206(333)265-151(105-277)181(308)237-101-162(287)239-117(12)213(340)276-87-44-62-158(276)214(341)275-86-43-61-157(275)208(335)268-153(107-279)204(331)249-132(56-30-38-81-221)187(314)246-131(55-29-37-80-220)186(313)245-130(54-28-36-79-219)185(312)244-129(53-27-35-78-218)184(311)243-128(52-26-34-77-217)183(310)242-127(176(227)303)51-25-33-76-216)272-201(328)146(92-120-45-19-17-20-46-120)260-197(324)144(90-112(4)5)257-190(317)135(59-41-84-231-215(228)229)255-209(336)172(114(8)9)271-177(304)116(11)240-182(309)138(65-71-167(293)294)251-192(319)139(66-72-168(295)296)252-193(320)140(67-73-169(297)298)253-195(322)142(75-88-342-15)254-191(318)137(63-69-159(225)284)250-188(315)133(57-31-39-82-222)248-203(330)152(106-278)266-198(325)145(91-113(6)7)259-200(327)150(97-171(301)302)263-205(332)155(109-281)269-212(339)175(119(14)283)273-202(329)147(93-121-47-21-18-22-48-121)264-211(338)174(118(13)282)270-164(289)103-236-179(306)136(64-70-166(291)292)241-163(288)102-234-178(305)125(224)95-123-99-230-110-238-123/h17-24,45-50,98-99,110-119,125,127-158,172-175,232,277-283H,16,25-44,51-97,100-109,216-224H2,1-15H3,(H2,225,284)(H2,226,285)(H2,227,303)(H,230,238)(H,233,286)(H,234,305)(H,235,307)(H,236,306)(H,237,308)(H,239,287)(H,240,309)(H,241,288)(H,242,310)(H,243,311)(H,244,312)(H,245,313)(H,246,314)(H,247,323)(H,248,330)(H,249,331)(H,250,315)(H,251,319)(H,252,320)(H,253,322)(H,254,318)(H,255,336)(H,256,337)(H,257,317)(H,258,326)(H,259,327)(H,260,324)(H,261,321)(H,262,316)(H,263,332)(H,264,338)(H,265,333)(H,266,325)(H,267,334)(H,268,335)(H,269,339)(H,270,289)(H,271,304)(H,272,328)(H,273,329)(H,291,292)(H,293,294)(H,295,296)(H,297,298)(H,299,300)(H,301,302)(H4,228,229,231)/t115-,116-,117-,118+,119+,125-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,147-,148-,149-,150-,151-,152-,153-,154-,155-,156-,157-,158-,172-,173-,174-,175-/m0/s1
InChIKey XVVOERDUTLJJHN-IAEQDCLQSA-N
SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O
Roles Classification
Chemical Role(s): Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
Biological Role(s): glucagon-like peptide-1 receptor agonist
An agonist that binds to and activates glucagon-like peptide-1 (GLP-1) receptors.
Application(s): neuroprotective agent
Any compound that can be used for the treatment of neurodegenerative disorders.
hypoglycemic agent
A drug which lowers the blood glucose level.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing lixisenatide (CHEBI:85662) has role glucagon-like peptide-1 receptor agonist (CHEBI:71196)
lixisenatide (CHEBI:85662) has role hypoglycemic agent (CHEBI:35526)
lixisenatide (CHEBI:85662) has role neuroprotective agent (CHEBI:63726)
lixisenatide (CHEBI:85662) is a peptidyl amide (CHEBI:15722)
lixisenatide (CHEBI:85662) is a polypeptide (CHEBI:15841)
IUPAC Name
L-histidylglycyl-L-α-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-α-aspartyl-L-leucyl-L-seryl-L-lysyl-L-glutaminyl-L-methionyl-L-α-glutamyl-L-α-glutamyl-L-α-glutamyl-L-alanyl-L-valyl-L-arginyl-L-leucyl-L-phenylalanyl-L-isoleucyl-L-α-glutamyl-L-tryptophyl-L-leucyl-L-lysyl-L-asparaginylglycylglycyl-L-prolyl-L-seryl-L-serylglycyl-L-alanyl-L-prolyl-L-prolyl-L-seryl-L-lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysinamide
INNs Sources
lixisenatida WHO MedNet
lixisenatide WHO MedNet
lixisénatide WHO MedNet
lixisenatidum WHO MedNet
Synonyms Sources
AQVE-10010 ChemIDplus
AVE 0010 ChemIDplus
AVE0010 ChemIDplus
des-38-proline-exendine-4 (Heloderma suspectum)-(1-39)-peptidylpenta-L-lysyl-L-lysinamide ChemIDplus
DesPro38Exendin-4(1-39)-Lys6-NH2 ChemIDplus
H-HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPSKKKKKK-NH2 ChEBI
H-HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPSKKKKKK-NH2 ChEBI
H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Ser-Lys-Lys-Lys-Lys-Lys-Lys-NH2 ChEBI
H-L-His-Gly-L-Glu-Gly-L-Thr-L-Phe-L-Thr-L-Ser-L-Asp-L-Leu-L-Ser-L-Lys-L-Gln-L-Met-L-Glu-L-Glu-L-Glu-L-Ala-L-Val-L-Arg-L-Leu-L-Phe-L-Ile-L-Glu-L-Trp-L-Leu-L-Lys-L-Asn-Gly-Gly-L-Pro-L-Ser-L-Ser-Gly-L-Ala-L-Pro-L-Pro-L-Ser-L-Lys-L-Lys-L-Lys-L-Lys-L-Lys-L-Lys-NH2 ChEBI
ZP 10 ChemIDplus
ZP10A peptide ChemIDplus
Brand Names Sources
Adlyxin ChEBI
Lyxumia ChemIDplus
Manual Xrefs Databases
4815 DrugCentral
D09729 KEGG DRUG
Lixisenatide Wikipedia
View more database links
Registry Numbers Types Sources
23952540 Reaxys Registry Number Reaxys
320367-13-3 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
19629885 PubMed citation Europe PMC
21391833 PubMed citation Europe PMC
23537041 PubMed citation Europe PMC
23558600 PubMed citation Europe PMC
23825925 PubMed citation Europe PMC
23992745 PubMed citation Europe PMC
24086950 PubMed citation Europe PMC
24122776 PubMed citation Europe PMC
24363554 PubMed citation Europe PMC
24373190 PubMed citation Europe PMC
24476092 PubMed citation Europe PMC
24583037 PubMed citation Europe PMC
24641271 PubMed citation Europe PMC
24683832 PubMed citation Europe PMC
24876548 PubMed citation Europe PMC
25012990 PubMed citation Europe PMC
25027491 PubMed citation Europe PMC
25055456 PubMed citation Europe PMC
25066229 PubMed citation Europe PMC
25107586 PubMed citation Europe PMC
25115916 PubMed citation Europe PMC
25119443 PubMed citation Europe PMC
25130920 PubMed citation Europe PMC
25195184 PubMed citation Europe PMC
25773712 PubMed citation Europe PMC
25802728 PubMed citation Europe PMC
25853868 PubMed citation Europe PMC
25887358 PubMed citation Europe PMC
25965710 PubMed citation Europe PMC
26342556 PubMed citation Europe PMC
26423184 PubMed citation Europe PMC
26537183 PubMed citation Europe PMC
26594250 PubMed citation Europe PMC
26630143 PubMed citation Europe PMC
26701217 PubMed citation Europe PMC
26770666 PubMed citation Europe PMC
26787264 PubMed citation Europe PMC
26981945 PubMed citation Europe PMC
26981946 PubMed citation Europe PMC
26981947 PubMed citation Europe PMC
27092017 PubMed citation Europe PMC
27222510 PubMed citation Europe PMC
27252787 PubMed citation Europe PMC
27267268 PubMed citation Europe PMC
27284114 PubMed citation Europe PMC
27310712 PubMed citation Europe PMC
27311491 PubMed citation Europe PMC
27319011 PubMed citation Europe PMC
27341040 PubMed citation Europe PMC
Last Modified
10 August 2017